drugset / Trial / NCT06258213
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral ABP-745 Administration in Healthy Volunteers
RandomizedSequentialTriple-blindOther
Summary
A randomized, double-blind, placebo-controlled, dose-escalation study will be conducted in healthy volunteers. This study will evaluate the safety, tolerability, and pharmacokinetics (PK) of ABP-745 following single (Part 1) and multiple (Part 2) oral doses.
Timeline
- Start
- 2024-01-23
- Primary completion
- 2024-07-29
- Completion
- 2024-07-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | ABP-745 | Unknown | 0.5 mg | Oral |
| Comparator | ABP-745 | Unknown | 5 mg | Oral |
| Comparator | ABP-745 | Unknown | 25 mg | Oral |